
A new blood test approved by the U.S. Food and Drug Administration can predict imminent preeclampsia, helping pregnant women who are at risk of this severe and sometimes deadly form of high blood pressure. The test can identify with 96% accuracy which women with sometimes-vague symptoms will develop preeclampsia within the following two weeks, The New York Times reported this week. “It’s groundbreaking. It’s revolutionary,” Dr. Douglas Woelkers, a professor of maternal-fetal medicine at the University of California, San Diego, said of the test. “It’s the first step forward in preeclampsia diagnostics since 1900, when the condition was first defined,” Woelkers added in the news report. The blood test was created by Thermo Fisher Scientific. It is meant for women in the 23rd to 35th weeks of pregnancy. Those who don’t test positive can be safely discharged from the hospital, while two-thirds of those with a positive result will advance to severe preeclampsia. Women who are positive may need to deliver their babies early. “We don’t have a therapy that reverses or cures preeclampsia other than delivery of the baby, which is more like a last resort,” Woelkers said in the news report. Black women are particularly at risk of preeclampsia, with much higher rates than white women. They are also more likely to experience kidney damage, death and to lose their babies, the Times… read on > read on >